Venture Capital · Munich (Germany) · Founded 2018
415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.
Series A, Series B
Healthcare, MedTech, Neuromodulation for Chronic Diseases, Neurovascular Disease / Stroke, Patient Monitoring, Structural Heart Disease
Laza Medical, Supira Medical, R3 Vascular, CorFlow Therapeutics, Cardiac Success, Aktiia, Distalmotion, TRiCares, Vesper Medical, CoRRect Medical, Intact Vascular, Mitralign, Rebound Therapeutics, Claret Medical, Essential Medical, ImThera Medical, ReCor Medical, Boston Heart Diagnostics, CardiAQ Valve Technologies, Loma Vista Medical, Atritech, Embrella Cardiovascular, CoreValve, OVUM Ventures, ArteriA Technologies, Micrus Endovascular, ACIST, Cardiologic, Embolic Protection System, Vascular Solutions, Endologix, Vascular Science